BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1618230)

  • 61. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma.
    Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ
    J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunoscintigraphy of venous thrombi: clinical effectiveness of a new antifibrin D-dimer monoclonal antibody.
    Ciavolella M; Tavolaro R; Di Loreto M; La Torre F; Nicolai A; Schillaci O; Ierardi M; Scopinaro F
    Angiology; 1999 Feb; 50(2):103-9. PubMed ID: 10063940
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A novel anti-seminoma monoclonal antibody (M2A) labelled with technetium-99m: potential application for radioimmunoscintigraphy.
    Marks A; Ballinger JR; Reilly RM; Law J; Baumal R
    Br J Urol; 1995 Feb; 75(2):225-9. PubMed ID: 7850331
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An instant kit method for labeling antimyosin Fab' with technetium-99m: evaluation in an experimental myocardial infarct model.
    Pak KY; Nedelman MA; Kanke M; Khaw BA; Mattis JA; Strauss HW; Dean RT; Berger HJ
    J Nucl Med; 1992 Jan; 33(1):144-9. PubMed ID: 1730981
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Abnormal uptake of technetium-99m hexakis-2-methoxyisobutylisonitrile in a primary cardiac lymphoma.
    Medolago G; Virotta G; Pitì A; Tespili M; D'Adda F; Rottoli MR; Comotti B; Motta T; Orlandi C; Bertocchi C
    Eur J Nucl Med; 1992; 19(3):222-5. PubMed ID: 1533370
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
    Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
    J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
    Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of deep venous thrombi and pulmonary embolus with technetium-99m-DD-3B6/22 anti-fibrin monoclonal antibody Fab' fragment.
    Bautovich G; Angelides S; Lee FT; Greenough R; Bundesen P; Murray P; Schmidt P; Waugh R; Harris J; Cameron K
    J Nucl Med; 1994 Feb; 35(2):195-202. PubMed ID: 8294982
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Staging lung carcinoma with a Tc-99m labeled monoclonal antibody.
    Vansant JP; Johnson DH; O'Donnell DM; Stewart JR; Sonin AH; McCook BM; Powers TA; Salk DJ; Frist WH; Sandler MP
    Clin Nucl Med; 1992 Jun; 17(6):431-8. PubMed ID: 1319860
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis.
    Jamar F; Houssiau FA; Devogelaer JP; Chapman PT; Haskard DO; Beaujean V; Beckers C; Manicourt DH; Peters AM
    Rheumatology (Oxford); 2002 Jan; 41(1):53-61. PubMed ID: 11792880
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnosing suspected acute nonclassic appendicitis with sulesomab, a radiolabeled antigranulocyte antibody imaging agent.
    Passalaqua AM; Klein RL; Wegener WA; Crawford JA; Crow JP; Andrews DA; Goldenberg DM
    J Pediatr Surg; 2004 Sep; 39(9):1338-44. PubMed ID: 15359387
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tc-99m sestamibi imaging in the diagnostic assessment of patients with lymphomas: comparison with clinical and radiological evaluation.
    Maurea S; Acampa W; Varrella P; De Rosa V; Fimiani P; Abate G; Salvatore M
    Clin Nucl Med; 1998 May; 23(5):283-90. PubMed ID: 9596152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does gallium uptake in the pulmonary hila predict involvement by non-Hodgkin's lymphoma?
    Champion PE; Groshar D; Hooper HR; Palmer M; Catz Z; Belch A; McEwan A
    Nucl Med Commun; 1992 Oct; 13(10):730-7. PubMed ID: 1491837
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunoscintigraphy with a technetium-99m labelled anti-epithelial growth factor receptor antibody in patients with non-small cell lung cancer.
    Schillaci O; Danieli R; Picardi V; Bagni O; Di Loreto M; Scopinaro F
    Anticancer Res; 2001; 21(5):3571-4. PubMed ID: 11848525
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dosimetry of rhenium-186-labeled monoclonal antibodies: methods, prediction from technetium-99m-labeled antibodies and results of phase I trials.
    Breitz HB; Fisher DR; Weiden PL; Durham JS; Ratliff BA; Bjorn MJ; Beaumier PL; Abrams PG
    J Nucl Med; 1993 Jun; 34(6):908-17. PubMed ID: 8509857
    [TBL] [Abstract][Full Text] [Related]  

  • 77. FDG-PET, 99mtc-HMPAO white blood cell SPET and bone scintigraphy in the evaluation of painful total knee arthroplasties.
    Van Acker F; Nuyts J; Maes A; Vanquickenborne B; Stuyck J; Bellemans J; Vleugels S; Bormans G; Mortelmans L
    Eur J Nucl Med; 2001 Oct; 28(10):1496-504. PubMed ID: 11685492
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences.
    Alexander C; Villena-Heinsen CE; Trampert L; Lung-Kurt S; Oberhausen E; Kirsch CM; Schmidt W
    Eur J Nucl Med; 1995 Jul; 22(7):645-51. PubMed ID: 7498226
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Site-specific conjugation and labelling of prostate antibody 7E11C5.3 (CYT-351) with technetium-99m.
    Stalteri MA; Mather SJ; Belinka BA; Coughlin DJ; Chengazi VU; Britton KE
    Eur J Nucl Med; 1997 Jun; 24(6):651-4. PubMed ID: 9169572
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunoscintigraphy of tumours using 99Tcm-labelled monoclonal antibodies: a review.
    Reilly RM
    Nucl Med Commun; 1993 May; 14(5):347-59. PubMed ID: 8510874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.